Tripotassium dicitratobismuthate
ArticlesMedicine Compliance Aid StabilityLactation Safety Information · Published , updated
10044211000001103
Articles
21 September 2020
Safety in Lactation: Drugs for disorders of gastric acid and ulceration
Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Drugs for dyspepsia Aluminium and magnesium… Aluminium hydroxide Cimetidine Co-magaldrox Esomeprazole Famotidine Gastrointestinal disorders Hydrotalcite Lansoprazole Magnesium carbonate Magnesium trisilicate Misoprostol Nizatidine Omeprazole Pantoprazole Rabeprazole Ranitidine Safety in Breastfeeding Simeticone Sodium alginate + Magnesium alginate Sucralfate Tripotassium dicitratobismuthateMedicine Compliance Aid Stability
De-NoltabAstellas Pharma Ltd
Astellas Pharma Ltd
De-Noltab
Tablets f/c
R1 · Red 1Stability data indicates that the drug is not suitable for CAs.
Unsuitable
Complex administration schedule makes this drug unsuitable for inclusion in MCA.
4 November 2015
Lactation Safety Information
Sucralfate
No published evidence of safety
Minimal GI absorption by the mother and infant
Used in infants >1 month
11 July 2016